Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption

MeSH terms

• Carcinoma, Transitional Cell* / drug therapy
• Cell Adhesion Molecules
• Erythema / chemically induced
• Erythema / diagnosis
• Humans
• Immunoconjugates*
• Nectins
• Urinary Bladder Neoplasms* / drug therapy
• Urinary Bladder Neoplasms* / pathology